Physician
Interventional Pain & Spine Specialists LLC
Interventional Pain & Spine Specialists LLC was paid $6.25M by Medicaid between Jan 2020 and Aug 2024, across 42 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 34% of everything it billed.
33Billing provider infoINTERVENTIONAL PAIN & SPINE SPECIALISTS LLC
LEXINGTON, KY 40509
LEXINGTON, KY 40509
33aNPI1184110231assigned 07/02/2018
33bProvider typeAnesthesiology Physician
28Total paid$6.25M
24GClaims144,320
24DCodes billed42
24AFirst – last monthJan 2020 – Aug 2024
Compared with peers
Next to other Anesthesiology Physician providers in Kentucky
Rank by total paid#3 of 46
Median peer was paid$68K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FISHER, TAMIA controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 40,821 | $1.68M | |
| 2021 | 55,383 | $2.78M | |
| 2022 | 22,582 | $762K | |
| 2023 | 17,875 | $701K | |
| 2024incomplete | 7,659 | $320K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 34% | 57,793 | 53,358 | $2.11M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 56,084 | 51,764 | $1.73M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 10% | 4,425 | 4,164 | $627K |
| 64635 | 5.0% | 1,107 | 1,023 | $313K | |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 3.4% | 393 | 323 | $214K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 2.8% | 1,497 | 1,251 | $177K |
| 64493 | 2.5% | 1,562 | 1,258 | $154K | |
| 64636 | 2.2% | 1,261 | 992 | $137K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.6% | 1,051 | 975 | $100K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.6% | 2,119 | 2,001 | $99K |
| 62323 | 1.4% | 711 | 651 | $88K | |
| 64494 | 1.3% | 1,646 | 1,232 | $80K |
30 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 849 | $70K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 918 | $55K |
| 27096 | <1% | 260 | $48K | |
| 77002 | <1% | 1,519 | $46K | |
| 20610 | <1% | 1,007 | $36K | |
| 95886 | <1% | 442 | $32K | |
| 76942 | <1% | 612 | $25K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,801 | $14K |
| 64490 | <1% | 135 | $13K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,418 | $13K |
| 62370 | <1% | 235 | $11K | |
| 95913 | <1% | 57 | $9K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 366 | $7K |
| 64491 | <1% | 124 | $6K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 754 | $6K |
| 62321 | <1% | 43 | $5K | |
| 80305 | <1% | 514 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,174 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 40 | $3K |
| 95912 | <1% | 17 | $3K | |
| 95910 | <1% | 18 | $2K | |
| 95911 | <1% | 16 | $2K | |
| 62368 | <1% | 71 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 184 | $727.26 |
| 64450 | <1% | 21 | $632.37 | |
| 20553 | <1% | 13 | $494.48 | |
| 76000 | <1% | 12 | $342.20 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 25 | $287.80 |
| 62367 | <1% | 13 | $75.79 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $8.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISHER, TAMIA (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Commonwealth Pain Specialists, PLLC | Frankfort, KY | $2.14M |
| Vitality DX LLC | Lexington, KY | $2.05M |
| Interventional Pain & Spine Specialists LLC | Lexington, KY | $1.22M |
| Interventional Pain & Spine Specialists LLC | Evansville, IN | $522K |
| Interventional Pain & Spine Specialists, LLC | Louisville, KY | $462K |
| Interventional Pain & Spine Specialists LLC | Bowling Green, KY | $374K |
| Interventional Pain & Spine Specialists LLC | Louisville, KY | $323K |
| Interventional Pain & Spine Specialists LLC | Bowling Green, KY | $308K |
| Interventional Pain & Spine Specialists LLC | Frankfort, KY | $177K |
| Interventional Pain & Spine Specialists LLC | Louisville, KY | $136K |
| Vitality Pain Management LLC | Bowling Green, KY | $116K |
| X-Gene Molecular Laboratories, INC | Louisville, KY | $50K |
| Kingdom Counseling | Chandler, IN | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.